EGFR and neoplasm: Furthermore, wild-type FBXL2, but not FBXL2C420S, dramatically inhibited PC-9/AZDR xenograft tumor growth, concomitant with significantly reduced EGFR expression and Ki67+ cells (Fig. 7e−g and Supplementary Fig. 10g).